Cervical/Thoracic Neuromodulation and Nociceptive Processing
Launched by UNIVERSITÉ CATHOLIQUE DE LOUVAIN · Apr 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how a specific type of electrical stimulation, called transcutaneous spinal direct current stimulation (tsDCS), affects pain processing in the body. Researchers want to see if applying this stimulation to the cervical (neck) area of the spine can influence how we feel pain, similar to what has been observed with stimulation of the low-thoracic (mid-back) area. The study involves healthy young adults and aims to compare the effects of these two stimulation methods on pain processing.
To participate, you would need to be a healthy young adult aged between 18 and 35 years old. However, certain medical conditions like diabetes, neurological disorders, and the use of specific medications may prevent you from joining. If you take part in the study, you will receive either the actual stimulation or a "sham" (placebo) treatment, meaning you won’t know which one you’re getting. This helps researchers understand the true effects of the treatment without bias. The trial is currently recruiting participants, and it’s a great opportunity to contribute to important research on pain management.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy young adults
- Exclusion Criteria:
- • Known medical conditions (e.g., diabetes, neuropathy, psychiatric disorders, seizure, migraine, pacemaker or other implanted medical devices...)
- • Use of any medication (except contraception)
About Université Catholique De Louvain
Université Catholique de Louvain (UCLouvain) is a prestigious Belgian institution renowned for its commitment to academic excellence, research innovation, and interdisciplinary collaboration. With a strong emphasis on advancing medical science and improving patient outcomes, UCLouvain conducts a range of clinical trials across various medical fields. The university's research initiatives are supported by cutting-edge facilities and a team of experienced professionals, fostering a robust environment for clinical investigation. UCLouvain is dedicated to ethical research practices and aims to contribute significantly to the global body of medical knowledge through its clinical trial endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, , Belgium
Patients applied
Trial Officials
André Mouraux, MD, PhD
Principal Investigator
Université Catholique de Louvain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported